- Nelson Advisors LLP
- About Us
- Contact Us
- Message Us
- Meet Us
- FAQ's
- Mission and Vision
- Expertise
- Services
- Lower to Mid Market
- Corporate Divestitures
- Healthcare AI
- Digital Health
- Transactions
- Behaviour Change
- App Platform Data AI
- Research
- University Business Schools
- Thought Leadership
- Careers
- Lloyd G Price
- Press and Awards
- Blog
- Insights
- Newsletter
Nelson Advisors HLTH Europe 2026 - The Exit Factor: Why M&A is on the rise in HealthTech
Mar 03, 2026·By Nelson Advisors
NA
The Exit Factor: Why M&A is on the rise in HealthTech
Wednesday, 17 June 2026
Time: 9:00 AM - 9:40 AM
Track 1, Panel
Forget IPOs. Europe’s healthtech story is increasingly being written by buyers. Corporates want fresh tech, investors want liquidity, and the cheques are getting bigger.
By mid-2025 healthcare deal value had soared 87% to €31.8 billion, even as deal count slid 8% according to Nelson Advisors. In the UK, 168 healthtech exits landed by the end of 2024 against just 61 failures. M&A is no longer a side strategy; it’s the headline act and primary way buyers access innovation, capability, and competitive edge.
Source: https://hlth.com/events/europe/agenda/2026/the-exit-factor-why-m-and-a-is-on-the-rise-in-healthtech